Inhibition of apoptosis in human retinal pigment epithelial cells treated with benzo(e)pyrene, a toxic component of cigarette smoke

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 5, 2010, Pages 2601-2607

  Mansoor, Saffar ^a   Gupta, Navin ^a   Patil, A Jayaprakash ^a,b,c,d   Estrago Franco, Maria Fernanda ^a   Ramirez, Claudio ^a   Migon, Rafael ^a   Sapkal, Ashish ^a   Kuppermann, Baruch D ^a   Kenney, M Cristina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

^c NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^d ROYAL LANCASTER INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; BENZYL ISOTHIOCYANATE; CALPAIN; CASPASE 3; CASPASE 7; CASPASE 9; EPICATECHIN; GENISTEIN; MEMANTINE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIMVASTATIN; BENZO[A]PYRENE DERIVATIVE; BENZO[E]PYRENE; STILBENE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PIGMENT CELL; PRIORITY JOURNAL; CELL LINE; CELL SURVIVAL; METABOLISM; PATHOLOGY; PIGMENT EPITHELIUM; SMOKING;

APOPTOSIS; BENZOPYRENES; CASPASE 3; CASPASE 7; CASPASE 9; CELL LINE; CELL SURVIVAL; GENISTEIN; HUMANS; MEMANTINE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RETINAL PIGMENT EPITHELIUM; SMOKING; STILBENES;

EID: 77952540837     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4121     Document Type: Article

References (60)

1. Friedman DS, O'Colmain BJ, Munoz B, et al. Prevalence of agerelated macular degeneration in the United States. Arch Ophthalmol. 2004;122(4):564-572.
2. Thornton J, Edwards R, Mitchell P, et al. Smoking and age-related macular degeneration: a review of association. Eye. 2005;19(9):935-944.
3. Khan JC, Thurlby DA, Shahid H, et al. Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol. 2006;90(1):75-80.
4. Klein R, Knudtson MD, Cruickshanks KJ, Klein BE. Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol. 2008;126(1):115-121.
5. Del Priore LV, Kuo YH, Tezel TH. Age-related changes in human RPE cell density and apoptosis proportion in situ. Invest Ophthalmol Vis Sci. 2002;43(10):3312-3318.
6. Dunaief JL, Dentchev T, Ying GS, Milam AH. The role of apoptosis in age-related macular degeneration. Arch Ophthalmol. 2002; 120(11):1435-14 42.
7. Falahatpisheh M, Kerzee J, Metz R, et al. Inducible cytochrome P450 activities in renal glomerular mesangial cells: biochemical basis for antagonistic interactions among nephrocarcinogenic polycyclic aromatic hydrocarbons. J Carcinog. 2004;3(1):12.
8. Vakharia DD, Liu N, Pause R, et al. Polycyclic aromatic hydrocarbon/ metal mixtures: effect on PAH induction of CYP1A1 in human HEPG2 cells. Drug Metab Dispos. 2001;29(7):999-1006.
9. Heidel SM, MacWilliams PS, Baird WM, et al. Cytochrome P4501B1 mediates induction of bone marrow cytotoxicity and preleukemia cells in mice treated with 7,12-dimethylbenz[a]anthracene. Cancer Res. 2000;60(13):3454-3460.
10. Patton WP, Routledge MN, Jones GD, et al. Retinal pigment epithelial cell DNA is damaged by exposure to benzo[a]pyrene, a constituent of cigarette smoke. Exp Eye Res. 2002;74(4):513-522.
11. Sharma A, Neekhra A, Gramajo AL, et al. Effects of benzo (e) pyrene, a toxic component of cigarette smoke, on human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci. 2008; 49(11):5111-117.
12. Dresser R. Weighing the benefits of new Alzheimer's treatments. Science. 2000;289(5481):869b.
13. Wilkinson D. Drugs for treatment of Alzheimer's disease. Int J Clin Pract. 2001;55(2):129-134.
14. Johnson-Anuna LN, Eckert GP, Franke C, et al. Simvastatin protects neurons from cytotoxicity by up-regulating Bcl-2 mRNA and protein. J Neurochem. 2007;101(1):77-86.
15. Du Y, Guo H, Lou H. Grape seed polyphenols protect cardiac cells from apoptosis via induction of endogenous antioxidant enzymes. J Agric Food Chem. 2007;55(5):1695-1701.
16. Sorimachi H, Ishiura S, Suzuki K. Structure and physiological function of calpains. Biochem J. 1997;328(Pt 3):721-732.
17. Glading A, Lauffenburger DA, Wells A. Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol. 2002;12(1):46-54.
18. Carragher NO. Calpain inhibition: a therapeutic strategy targeting multiple disease states. Curr Pharm Des. 2006;12(5):615-6 38.
19. Zhang L, Song L, Parker EM. Calpain inhibitor I increases betaamyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase: evidence that substrate availability limits beta-amyloid peptide production. J Biol Chem. 1999; 274(13):8966-8972.
20. Whiteman M, Armstrong JS, Cheung NS, et al. Peroxynitrite mediates calcium-dependent mitochondrial dysfunction and cell death via activation of calpains. FASEB J. 2004;18(12):1395-1397.
21. Nakamura Y, Ohigashi H, Masuda S, et al. Redox regulation of glutathione S-transferase induction by benzyl isothiocyanate: correlation of enzyme induction with the formation of reactive oxygen intermediates. Cancer Res. 2000;60(2):219-225.
22. Hecht SS. Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev. 2000;32(3-4):395-411.
23. Polkowski K, Mazurek AP. Biological properties of genistein: a review of in vitro and in vivo data. Acta Pol Pharm. 2000;57(2):135-155.
24. Majji AB, Hayashi A, Kim HC, et al. Inhibition of choriocapillaris regeneration with genistein. Invest Ophthalmol Vis Sci. 1999; 40(7):1477-1486.
25. Sonee M, Sum T, Wang C, Mukherjee SK. The soy isoflavone, genistein, protects human cortical neuronal cells from oxidative stress. Neurotoxicology. 2004;25(5):885-891.
26. Ulrich S, Wolter F, Stein JM. Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in carcinogenesis. Mol Nutr Food Res. 2005;49(5):452-461.
27. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493-506.
28. Cotelle N. Role of flavonoids in oxidative stress. Curr Top Med Chem. 2001;1(6):569-590.
29. Narayanan R, Kenney MC, Kamjoo S, et al. Trypan blue: effect on retinal pigment epithelial and neurosensory retinal cells. Invest Ophthalmol Vis Sci. 2005;46(1):304-309.
30. Chwa M, Atilano SR, Reddy V, et al. Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts. Invest Ophthalmol Vis Sci. 2006;47(5):1902-1910.
31. Clemons TE, Milton RC, Klein R, et al. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology. 2005;112(4):533-539.
32. Klein R. Overview of progress in the epidemiology of age-related macular degeneration. Ophthalmic Epidemiol. 2007;14(4):184-187.
33. Michels S, Kurz-Levin M. [Age-related macular degeneration (AMD)]. Ther Umsch. 2009;66(3):189-195.
34. Cohen GM. Caspases: the executioners of apoptosis. Biochem J. 1997;326(pt 1):1-16.
35. Stennicke HR, Salvesen GS. Properties of the caspases. Biochim Biophys Acta. 1998;1387(1-2):17-31.
36. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 1998;17(25):3247-3259.
37. Chai F, Truong-Tran AQ, Ho LH, Zalewski PD. Regulation of caspase activation and apoptosis by cellular zinc fluxes and zinc deprivation: a review. Immunol Cell Biol. 1999;77(3):272-278.
38. Guo Y, Srinivasula SM, Druilhe A, et al. Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem. 2002;277(16):13430-1343 7.
39. Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci U S A. 1994;91(23):10771-10778.
40. Long J, Wang X, Gao H, et al. Malonaldehyde acts as a mitochondrial toxin: Inhibitory effects on respiratory function and enzyme activities in isolated rat liver mitochondria. Life Sci. 2006;79(15):1466-1472.
41. Li X, Liu Z, Luo C, et al. Lipoamide protects retinal pigment epithelial cells from oxidative stress and mitochondrial dysfunction. Free Radic Biol Med. 2008;44(7):1465-1474.
42. Block F, Schwarz M. Memantine reduces functional and morphological consequences induced by global ischemia in rats. Neurosci Lett. 1996;208(1):41-4 4.
43. Chen HS, Wang YF, Rayudu PV, et al. Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following postischemic administration and do not block maze learning or longterm potentiation. Neuroscience. 1998;86(4):1121-11 32.
44. Ju WK, Kim KY, Angert M, et al. Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina. Invest Ophthalmol Vis Sci. 2009; 50(2):707-716.
45. Hare WA, WoldeMussie E, Lai RK, et al. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: functional measures. Invest Ophthalmol Vis Sci. 2004;45(8):2625-26 39.
46. Hare WA, WoldeMussie E, Weinreb RN, et al. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: structural measures. Invest Ophthalmol Vis Sci. 2004;45(8):2640-26 51.
47. WoldeMussie E, Yoles E, Schwartz M, et al. Neuroprotective effect of memantine in different retinal injury models in rats. J Glaucoma. 2002;11(6):474-4 80.
48. Lagreze WA, Knorle R, Bach M, Feuerstein TJ. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci. 1998;39(6):1063-1066.
49. Caumont AS, Octave JN, Hermans E. Amantadine and memantine induce the expression of the glial cell line-derived neurotrophic factor in C6 glioma cells. Neurosci Lett. 2006;394(3):196-201.
50. Kusari J, Zhou S, Padillo E, et al. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocininduced diabetic rats. Invest Ophthalmol Vis Sci. 2007;48(11):5152-5159.
51. Anekonda TS, Adamus G. Resveratrol prevents antibody-induced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70. BMC Res Notes. 2008;1:122.
52. Sheu SJ, Bee YS, Chen CH. Resveratrol and large-conductance calcium-activated potassium channels in the protection of human retinal pigment epithelial cells. J Ocul Pharmacol Ther. 2008; 24(6):551-555.
53. Liu Q, Ju WK, Crowston JG, et al. Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage. Invest Ophthalmol Vis Sci. 2007;48(10):4580-4589.
54. Revel A, Raanani H, Younglai E, et al. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene. J Appl Toxicol. 2003; 23(4):255-261.
55. Wang B, Zou Y, Yuan ZL, Xiao JG. Genistein suppressed upregulation of vascular endothelial growth factor expression by cobalt chloride and hypoxia in rabbit retinal pigment epithelium cells. J Ocul Pharmacol Ther. 2003;19(5):457-464.
56. Li H, Pan JS, Wang B. Inhibitive effect of genistein on interleukin-8 expression in cultured human retinal pigment epithelial cells. Methods Find Exp Clin Pharmacol. 2006;28(5):295-299.
57. Leung HY, Yung LH, Poon CH, et al. Genistein protects against polycyclic aromatic hydrocarbon-induced oxidative DNA damage in non-cancerous breast cells MCF-10A. Br J Nutr. 2009;101(2):257-2 62.
58. Ruweler M, Anker A, Gulden M, et al. Inhibition of peroxideinduced radical generation by plant polyphenols in C6 astroglioma cells. Toxicol In Vitro. 2008;22(5):1377-1381.
59. Liu J, Ames BN. Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease. Nutr Neurosci. 2005;8(2):67-89.
60. Gao J, Zhu ZR, Ding HQ, et al. Vulnerability of neurons with mitochondrial dysfunction to oxidative stress is associated with downregulation of thioredoxin. Neurochem Int. 2007;50(2):379-385.